+1 213-510-3499 sales@vparesearch.com
+1 213-510-3499 sales@vparesearch.com
Home/ Healthcare
Industry Coverage

Healthcare Market Research & Reports

Healthcare is being revolutionized by telemedicine, AI‑assisted diagnostics, precision therapeutics, and value‑based care models. VPA Research provides exhaustive analyses of pharmaceutical pipelines, medical device innovation, digital health platforms, and hospital service trends. We track regulatory pathways (FDA, EMA), reimbursement shifts, and patient engagement strategies impacting adoption rates. With granular forecasts by therapy area, device type, and delivery model, our insights support life sciences companies, providers, payers, and investors in navigating a complex, patient‑centric healthcare landscape.

Latest Reports in Healthcare

Explore syndicated research, market outlooks, and sector-specific analysis curated for strategy and growth teams.

2457 reports available

Hernia Mesh Devices Market Size, Share and Growth Outlook, 2026: Analysis By Hernia Type (Inguinal Hernia, Incisional, Femoral Hernia, Umbilical Hernia, Epigastric Hernia), By Mesh Type (Synthetic Mesh, Biologic Mesh, Bio-Synthetic), By Mesh Material (Non-Absorbable, Partially-Absorbable, Fully-Absorbable), By Surgical Repair Technique (Open Repair, Laparoscopic Repair, Robotic-Assisted Repair), By End User (Hospitals, Ambulatory Surgical Centers, Clinics) Companies, and Country Forecast, 2021 to 2034

Global Hernia Mesh Devices Market size is forecast to increase from $5.02 Billion in 2026 to $8.56 Billion in 2034 at a CAGR of 6.9% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007607
Pages: 220 Pages

Hereditary Testing Market Size, Share and Growth Outlook, 2026: Analysis By Test Type (Diagnostic Testing, Predictive & Presymptomatic Testing, Carrier Screening, Prenatal & Newborn Testing, Pharmacogenomic Testing), By Technology (Next-Generation Sequencing , PCR-based Testing, Microarray, Sanger Sequencing, Cytogenetic Testing), By Indication (Hereditary Cancer Testing, Hereditary Non-Cancer Testing ), By End User (Hospitals & Specialty Clinics, Diagnostic Laboratories, Academic & Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global Hereditary Testing Market size is forecast to increase from $21.04 Billion in 2026 to $62.59 Billion in 2034 at a CAGR of 14.6% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007606
Pages: 211 Pages

Hereditary Cancer Testing Market Size, Share and Growth Outlook, 2026: Analysis By Test Type (Multi-Gene Panel Testing, Single-Site ), By Indication (Breast Cancer, Ovarian Cancer, Colorectal Cancer, Prostate Cancer, Lung Cancer, Melanoma & Other Inherited Malignancies), By Technology (Molecular Testing , Polymerase Chain Reaction , Cytogenetic & Biochemical Testing), By Sample & Diagnosis Type (Biopsy , Imaging-Assisted Testing), By End-User (Diagnostic Laboratories & Reference Centers, Hospitals & Cancer Treatment Centers, Specialized Genetics & Oncology Clinics, Direct-to-Consumer Genetic Testing Platforms) Companies, and Country Forecast, 2021 to 2034

Global Hereditary Cancer Testing Market size is forecast to increase from $5.81 Billion in 2026 to $16.69 Billion in 2034 at a CAGR of 14.1% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007605
Pages: 211 Pages

Hereditary Angioedema Therapeutics Market Size, Share and Growth Outlook, 2026: Analysis By Drug Class (Kallikrein Inhibitors, C1-Inhibitor Concentrates, Bradykinin B2 Receptor Antagonists, Gene and RNA-Based Therapies), By Treatment Strategy Focus (Prophylaxis Treatment , On-Demand ), By Route of Administration (Intravenous, Subcutaneous, Oral), By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Online ), By End-User (Hospitals, Specialty Clinics, Homecare Settings) Companies, and Country Forecast, 2021 to 2034

Global Hereditary Angioedema Therapeutics Market size is forecast to increase from $4.29 Billion in 2026 to $9.33 Billion in 2034 at a CAGR of 10.2% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007604
Pages: 212 Pages

Herceptin Market Size, Share and Growth Outlook, 2026: Analysis By Product (Biologic , Biosimilars), By Indication (Adjuvant Breast Cancer, Metastatic Breast Cancer, Metastatic Gastric , Other HER2-Positive Malignancies), By Route of Administration (Intravenous , Subcutaneous ), By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Online ), By End-User (Hospitals & Health Systems, Oncology Centers & Specialty Clinics, Ambulatory Infusion Centers) Companies, and Country Forecast, 2021 to 2034

Global Herceptin Market size is forecast to increase from $4.11 Billion in 2026 to $6.36 Billion in 2034 at a CAGR of 5.6% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007603
Pages: 211 Pages

Herbal Supplements Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Turmeric, Ginger, Ginseng, Moringa, Echinacea, Flaxseeds, Others), By Form (Tablets and Capsules, Powders, Gummies, Softgels, Liquids), By Application (Pharmaceuticals, Personal Care and Cosmetics, Functional Foods and Beverages), By Distribution Channel (Offline Stores, Online Stores, Direct-to-Consumer) Companies, and Country Forecast, 2021 to 2034

Global Herbal Supplements Market size is forecast to increase from $52.35 Billion in 2026 to $99.07 Billion in 2034 at a CAGR of 8.3% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007602
Pages: 214 Pages

Herbal Medicine Market Size, Share and Growth Outlook, 2026: Analysis By Intervention (Ayurveda, Traditional Chinese Medicine, Naturopathic Medicine, Homeopathic Medicines, Aromatherapy Products, Other Traditional Systems), By Product Form (Tablets and Capsules, Powders, Liquids, Oils, Syrups), By Source (Roots, Leaves, Barks, Fruits and Vegetables), By Distribution Channel (Hospital and Retail Pharmacies, E-commerce, Direct Sales) Companies, and Country Forecast, 2021 to 2034

Global Herbal Medicine Market size is forecast to increase from $127.9 Billion in 2026 to $354.73 Billion in 2034 at a CAGR of 13.6% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007601
Pages: 218 Pages

HER2-Negative Breast Cancer Market Size, Share and Growth Outlook, 2026: Analysis By Receptor Status (Hormone Receptor-Positive , Triple-Negative Breast Cancer ), By Treatment Modality (Hormonal , Targeted Therapy , Chemotherapy, Immunotherapy , Radiation & Surgical Therapy), By Disease Stage (Early-Stage Breast Cancer, Locally Advanced Breast Cancer, Metastatic Breast Cancer), By Distribution Channel (Hospital Pharmacies, Specialty & Retail Pharmacies, Online) Companies, and Country Forecast, 2021 to 2034

Global HER2-Negative Breast Cancer Market size is forecast to increase from $29.02 Billion in 2026 to $55.33 Billion in 2034 at a CAGR of 8.4% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007600
Pages: 220 Pages

HER2-Positive Breast Cancer Market Size, Share and Growth Outlook, 2026: Analysis By Therapy Class (Monoclonal Antibodies (mAbs), Antibody-Drug Conjugates (ADCs), Tyrosine Kinase Inhibitors (TKIs), Companion Chemotherapies, Immune Checkpoint Inhibitors), By Biomarker Expression Level (Ultra-Positive (HER2+), HER2-Low & Ultra-Low), By Route of Administration (Intravenous (IV) Infusion, Subcutaneous (SC) Injection, Oral), By Application (Hospital Pharmacies, Oncology Clinics & Specialty Infusion Centers) Companies, and Country Forecast, 2021 to 2034

Global HER2-Positive Breast Cancer Market size is forecast to increase from $11.43 Billion in 2026 to $24.68 Billion in 2034 at a CAGR of 10.1% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007599
Pages: 218 Pages

HER2 Inhibitors Market Size, Share and Growth Outlook, 2026: Analysis By Drug Class (Monoclonal Antibodies , Antibody-Drug Conjugates , Small-Molecule Tyrosine Kinase Inhibitors , Bispecific ), By Therapeutic Application (Breast Cancer , Gastric & Gastroesophageal Junction Cancers, Non-Small Cell Lung Cancer , Colorectal Cancer, Tumor-Agnostic ), By Treatment Regimen (Monotherapy, Combination Therapy), By Route of Administration (Intravenous Infusion, Subcutaneous Injection, Oral Administration), By End-User (Cancer Centers & Oncology Clinics, Community & Government Hospitals, Specialty Pharmacies) Companies, and Country Forecast, 2021 to 2034

Global HER2 Inhibitors Market size is forecast to increase from $25.67 Billion in 2026 to $58.31 Billion in 2034 at a CAGR of 10.8% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007598
Pages: 213 Pages